LARGE1 (AA 35-142) anticorps (PE)
Aperçu rapide pour LARGE1 (AA 35-142) anticorps (PE) (ABIN2749158)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 35-142
-
Fonction
- Anti-LARGE1 PE
-
Specificité
- The mouse monoclonal antibody LARGE-02 recognizes human LARGE1, a glycosyltransferase expressed mainly in the Golgi apparatus. Crossreactivity with LARGE2 was not determined.
-
Réactivité croisée (Details)
- Human
-
Purification
- Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
-
Immunogène
- Recombinant fragment of human LARGE1 (amino acids 35-142)
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.1 mg/mL
-
Buffer
- Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
-
-
- LARGE1
-
Sujet
- LARGE xylosyl- and glucuronyltransferase 1,LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.,Xysosyl- and glucosyl transferase 1
-
ID gène
- 9215
-
UniProt
- O95461
Antigène
-